Breaking news

Apple Ordered To Remit $634 Million For Patent Infringement

Apple Inc. now faces a staggering $634 million judgment after a California federal jury found the tech giant infringed on Masimo’s patent regarding blood oxygen monitoring technology.

Landmark Intellectual Property Ruling

The verdict, reported by Reuters, centers on the Apple Watch’s workout and heart rate notification features, which the jury determined unlawfully incorporated Masimo’s patented pulse oximetry innovations. According to Masimo, a leader in medical device technology (Masimo), this legal win is a critical measure to safeguard their technological advancements that directly benefit patient care.

Strategic Implications For Apple

An Apple spokesperson noted plans to appeal the decision, contesting that the patent in question expired in 2022 and dated back to outdated patient monitoring methods. This response underscores a broader debate over legacy technologies versus evolving innovation paradigms.

Broader Context Of The Dispute

The contentious legal battle extends beyond patent infringement alone. Masimo has previously accused Apple of recruiting its talent, including the company’s chief medical officer, to leverage its pulse oximetry expertise. The United States International Trade Commission further bolstered Masimo’s stance in 2023 by banning Apple from importing devices featuring blood oxygen monitoring capabilities—a cautionary precedent that has prompted Apple to re-engineer the function to operate on the paired iPhone rather than the watch.

Counterlitigation And Ongoing Legal Challenges

As the litigation landscape evolves, Masimo is also challenging U.S. Customs and Border Patrol for approving the new Apple Watch imports, while Apple has escalated its contest to higher courts, seeking reversal of the import ban. In a related development, Apple secured a $250 statutory minimum in a countersuit after a jury found Masimo had infringed on its design patents.

This case not only highlights the high stakes involved in protecting intellectual property but also reflects the broader tensions at the intersection of innovation, talent acquisition, and competitive market dynamics in the technology sector.

Cyprus Expands RESTART Research Funding With Cybersecurity Measures

Cyprus has widened its support for research and innovation with an expanded version of the Restart 2016–2020 programmes, adding fresh funding capacity and a new cybersecurity-focused initiative designed to accelerate the commercialisation of innovative products and services.

Expanded Scheme Approved Under Existing State Aid Framework

State Aid Control Commissioner Stella Michaelidou has approved amendments to the measure titled “Restart 2016–2020 Programmes for Research, Technological Development and Innovation of the Research and Innovation Foundation”, allowing the continuation of the scheme under revised terms. The programme had already been deemed compatible with state aid rules under Decision No. 471, issued on July 18, 2025.

The updated framework reflects both a broader scope and a modest increase in the approved budget, underscoring Cyprus’ continuing effort to strengthen its innovation ecosystem and improve the country’s capacity to support applied research and new technology development.

New Cybersecurity Programme Targets Fast-Track Innovation

The most notable addition is the Fast Track Innovation (FTI) programme, which will support the rapid development of innovative products and services in the cybersecurity sector. The initiative is aimed at established businesses across all sectors that are investing in the fast delivery of internationally competitive solutions.

In practical terms, the new programme gives Cyprus a more targeted tool for backing high-potential innovation where speed to market can be decisive, particularly in a field such as cybersecurity, where demand is rising, and competitive advantage often depends on rapid execution.

Budget Increases To €308.4 Million

According to the Office of the State Aid Control Commissioner, the scheme’s approved budget has been increased from €306.9 million to €308.4 million. The expansion follows the earlier approval under Decision No. 471 and reflects the widening of the programme’s scope.

The revised measure also includes updated standard cost scales for staff remuneration and extends the deadline for funding decisions under the scheme to June 30, 2027.

Broad Eligibility Across The Innovation Ecosystem

The Restart scheme remains open to a wide range of beneficiaries, including research organisations, higher education institutions, scientific and professional bodies, businesses, business associations, non-governmental organisations, public services and public utility organisations.

Individuals such as academics, scientists, researchers, technical personnel, students and pupils may also take part in relevant programmes supported under the measure, broadening the pipeline of participation across Cyprus’ research and innovation landscape.

Strategic Push For Innovation Capacity

The State Aid Control Commissioner’s office said the measure was approved following a decision by the Board of Directors of the Research and Innovation Foundation and the issuance of the relevant state aid decision. Decision No. 488 was published in the Official Gazette of the Republic on July 10, 2026, and has also been made available on the commissioner’s website.

The revised Restart programme comes as Cyprus continues to invest in research, technological development and innovation as core drivers of long-term competitiveness. By increasing support for businesses, researchers and institutions developing new products, services and technologies, the government is signalling that innovation remains a strategic economic priority.

Aretilaw firm
The Future Forbes Realty Global Properties
eCredo
Uol

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter